gastroplustm v.9.7 (Simulations Plus Inc)
90
Structured Review
Simulations Plus Inc
gastroplustm v.9.7
Gastroplustm V.9.7, supplied by Simulations Plus Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gastroplustm+v%2E9%2E7/gastroplustm+v+9+7/pm40043822-48-10-12
Average 90 stars, based on 1 article reviews
Gastroplustm V.9.7, supplied by Simulations Plus Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gastroplustm+v%2E9%2E7/gastroplustm+v+9+7/pm40043822-48-10-12
Average 90 stars, based on 1 article reviews
gastroplustm v.9.7 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Physiologically-based pharmacokinetic modeling to predict the exposure and to assess pharmacodynamics of daptomycin in infants within 1 year old. Article Snippet: Daptomycin is widely used in pediatric patients for serious infections caused by Gram-positive bacteria, however, studies regarding its safety and efficacy in infants within 1 year old are very limited.. A physiologically-based pharmacokinetic (PBPK) model of daptomycin was built for children aged 1–17 years old and extrapolated to infants within 1 year old to evaluate pharmacodynamics (PD) based on efficacy and safety considerations.. Monte Carlo Simulations (MCSs) were conducted to determine the probabilities of target attainment (PTA) and cumulative fractions of response (CFR) of daptomycin. Article Title: Application of physiologically based pharmacokinetic modeling to predict the pharmacokinetics of telavancin in obesity with renal impairment Article Snippet: The PBPK modeling and simulations of telavancin were conducted using |